-
FDA approves first-in-human trial of COVID-19 vaccine candidate
europeanpharmaceuticalreview
November 02, 2020
The safety and immunogenicity of CORVax12, a novel DNA-encodable COVID-19 vaccine, will be evaluated in 36 healthy volunteers.
-
Moderna partners with Takeda for Covid-19 vaccines supply to Japan
pharmaceutical-technology
November 02, 2020
Moderna has announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical agreed to purchase and distribute 50 million doses of its Covid-19 vaccine candidate, mRNA-1273.
-
Activists urge pharma companies to be transparent about costs and terms of COVID-19 vaccine
expresspharma
November 02, 2020
No company has shared information on research and development, clinical trials or manufacturing costs of potential COVID-19 vaccines, MSF said.
-
Form committees for smooth COVID-19 vaccination drive: Centre to States
expresspharma
November 02, 2020
The committees will review preparatory activities in terms of cold chain preparedness, operational planning, strategies for state-specific challenges in terms of geographical terrain and hard-to-reach areas, etc.
-
J&J to test COVID-19 vaccine in youths aged 12-18
expresspharma
November 02, 2020
Johnson & Johnson plans to start testing its experimental COVID-19 vaccine in youths aged 12 to 18 as soon as possible, and the company’s previous experience with the same technology in a vaccine successfully used in children could give it a leg up ...
-
Bharat Biotech plans Covaxin launch in second quarter of 2021, post requisite approvals
expresspharma
November 02, 2020
Bharat Biotech is planning to launch its COVID-19 vaccine in the second quarter next year if it gets the requisite approvals from the Indian regulatory authorities, a top company official said.
-
UK MHRA commences accelerated review for AstraZeneca’s COVID-19 vaccine candidate
expresspharma
November 02, 2020
In rolling reviews, regulators can see clinical data in real-time and have discussions with pharma companies on manufacturing processes and trials to accelerate the approval process.
-
Takeda expands COVID-19 vaccine supply in Japan through partnership with Moderna and Government of Japan
worldpharmanews
October 30, 2020
Takeda Pharmaceutical Company Limited announced that it will import and distribute 50 million doses of Moderna's COVID-19 vaccine candidate, mRNA-1273, starting in the first half of 2021, pending licensure in Japan. This effort is part of a three-way ...
-
WHO to set up COVID-19 vaccine insurance scheme for 92 low-income countries
expresspharma
October 30, 2020
The scheme could foot the bill should anything go unexpectedly wrong after a COVAX-distributed vaccine is administered.
-
Clinical trials to study AstraZeneca’s COVID-19 vaccine resume globally
europeanpharmaceuticalreview
October 29, 2020
Clinical trials for AZD1222, the AstraZeneca COVID-19 vaccine candidate, have resumed across the world after confirmation it is safe to do so.